Search Results

Containing any of the words

Only of the type

A Phase 2 Open-label, Dose Escalation Study of HST5040 in Subjects with Propionic or Methylmalonic Acidemia Followed by a 6-Month, Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study and an Open-label, Long-term Extension Study Drug Clinical Trial

Pain-related behavior, pain perception and effectiveness of intraosseous local anesthesia (Quicksleeper 5) in pulpotomies of mandibular primary molars Clinical Trial

AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS Drug Clinical Trial

(SG-2003-208-H) COVID-19 - Requests for information regarding the off-label use of GE Healthcare anesthesia devices for ICU ventilation Medical Report

Common Quality Deficiencies Related to Impurities in Drug Substance Submissions for Generic Products Workshop

HRH Prince Sulman bin Abdul Aziz Welcomes SFDA’s President and Staff News

The SFDA: Overcoming Challenges, Delivering Results News

Form to update the list of approved establishments for processed fruit and vegetables Forms

How to request for (Adding, Editing, or Delisting) establishments exporting food to KSA in the Saudi FDA website? FAQ

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlodar Capsules (10 mg amlodipine) Produced by Dar AlDawa / Jordan versus Amlor® Capsules (10 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition. Drug Clinical Trial